1. Home
  2. DYAI vs UTSI Comparison

DYAI vs UTSI Comparison

Compare DYAI & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • UTSI
  • Stock Information
  • Founded
  • DYAI 1979
  • UTSI 1991
  • Country
  • DYAI United States
  • UTSI China
  • Employees
  • DYAI N/A
  • UTSI N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • UTSI Telecommunications Equipment
  • Sector
  • DYAI Health Care
  • UTSI Telecommunications
  • Exchange
  • DYAI Nasdaq
  • UTSI Nasdaq
  • Market Cap
  • DYAI 28.3M
  • UTSI 24.9M
  • IPO Year
  • DYAI 2004
  • UTSI 2000
  • Fundamental
  • Price
  • DYAI $1.01
  • UTSI $2.50
  • Analyst Decision
  • DYAI Strong Buy
  • UTSI
  • Analyst Count
  • DYAI 1
  • UTSI 0
  • Target Price
  • DYAI $6.00
  • UTSI N/A
  • AVG Volume (30 Days)
  • DYAI 58.3K
  • UTSI 7.5K
  • Earning Date
  • DYAI 08-12-2025
  • UTSI 09-04-2025
  • Dividend Yield
  • DYAI N/A
  • UTSI N/A
  • EPS Growth
  • DYAI N/A
  • UTSI N/A
  • EPS
  • DYAI N/A
  • UTSI N/A
  • Revenue
  • DYAI $3,554,344.00
  • UTSI $10,878,000.00
  • Revenue This Year
  • DYAI $22.56
  • UTSI N/A
  • Revenue Next Year
  • DYAI $30.95
  • UTSI N/A
  • P/E Ratio
  • DYAI N/A
  • UTSI N/A
  • Revenue Growth
  • DYAI 57.59
  • UTSI N/A
  • 52 Week Low
  • DYAI $0.91
  • UTSI $1.84
  • 52 Week High
  • DYAI $2.20
  • UTSI $3.22
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 55.41
  • UTSI 46.74
  • Support Level
  • DYAI $0.91
  • UTSI $2.40
  • Resistance Level
  • DYAI $1.03
  • UTSI $2.79
  • Average True Range (ATR)
  • DYAI 0.05
  • UTSI 0.13
  • MACD
  • DYAI 0.01
  • UTSI -0.01
  • Stochastic Oscillator
  • DYAI 83.00
  • UTSI 18.52

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

Share on Social Networks: